Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

442 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument.
Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, Ring L. Patrick DL, et al. Value Health. 2011 Dec;14(8):967-77. doi: 10.1016/j.jval.2011.06.014. Epub 2011 Oct 13. Value Health. 2011. PMID: 22152165 Free article.
Clinical Outcome Assessments: Conceptual Foundation-Report of the ISPOR Clinical Outcomes Assessment - Emerging Good Practices for Outcomes Research Task Force.
Walton MK, Powers JH 3rd, Hobart J, Patrick D, Marquis P, Vamvakas S, Isaac M, Molsen E, Cano S, Burke LB; International Society for Pharmacoeconomics and Outcomes Research Task Force for Clinical Outcomes Assessment. Walton MK, et al. Value Health. 2015 Sep;18(6):741-52. doi: 10.1016/j.jval.2015.08.006. Epub 2015 Aug 24. Value Health. 2015. PMID: 26409600 Free PMC article.
Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2--assessing respondent understanding.
Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, Ring L. Patrick DL, et al. Value Health. 2011 Dec;14(8):978-88. doi: 10.1016/j.jval.2011.06.013. Epub 2011 Oct 10. Value Health. 2011. PMID: 22152166 Free article.
Defining Patient Engagement in Research: Results of a Systematic Review and Analysis: Report of the ISPOR Patient-Centered Special Interest Group.
Harrington RL, Hanna ML, Oehrlein EM, Camp R, Wheeler R, Cooblall C, Tesoro T, Scott AM, von Gizycki R, Nguyen F, Hareendran A, Patrick DL, Perfetto EM. Harrington RL, et al. Among authors: patrick dl. Value Health. 2020 Jun;23(6):677-688. doi: 10.1016/j.jval.2020.01.019. Epub 2020 May 23. Value Health. 2020. PMID: 32540224 Free article.
Use of existing patient-reported outcome (PRO) instruments and their modification: the ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report.
Rothman M, Burke L, Erickson P, Leidy NK, Patrick DL, Petrie CD. Rothman M, et al. Among authors: patrick dl. Value Health. 2009 Nov-Dec;12(8):1075-83. doi: 10.1111/j.1524-4733.2009.00603.x. Epub 2009 Sep 25. Value Health. 2009. PMID: 19804437 Free article. Review.
442 results